期刊文献+

重组核心蛋白多糖对人正常皮肤和增生性瘢痕成纤维细胞增殖及生物学活性的影响 被引量:4

Effects of recombinant human decorin on proliferation and biological activity of normal human skin and hypertrophic scar fibroblasts in vitro
原文传递
导出
摘要 目的 观察重组核心蛋白多糖 (Decorin)对人正常皮肤和增生性瘢痕成纤维细胞体外增殖和生物学活性的影响 ,以探讨Decorin在增生性瘢痕形成和成熟中的作用。 方法 分离培养人正常皮肤和增生性瘢痕成纤维细胞 ,分别加入不同质量浓度 (0 .0 1,0 .1,2 ,10 μg/ml)的重组Decorin ;培养 12 ,2 4 ,4 8h用二甲基噻唑二苯基四唑溴盐 (MTT)法测定细胞增殖速度 ;培养 4 8h用流式细胞仪检测细胞周期和凋亡 ;收集细胞培养上清 ,ELISA法检测TGF - β1蛋白水平 ,放射免疫方法检测Ⅰ、Ⅲ型前胶原蛋白 (PCⅠ、PCⅢ )含量。 结果  2 ,10 μg/ml的Decorin可有效抑制正常皮肤和增生性瘢痕成纤维细胞的增殖 (P <0 .0 5或P <0 .0 1) ,明显增加两种细胞处于G1期的百分比(P <0 .0 1) ;并抑制细胞分泌转化生长因子 (TGF) - β1和PCⅠ、PCⅢ ,下调PCⅠ /PCⅢ比值。实验组和对照组 (未加重组Decorin)均未检测到终末期凋亡细胞。 结论 Decorin可抑制正常皮肤和增生性瘢痕成纤维细胞的增殖及其生物学活性 ,可能在预防增生性瘢痕形成和促进瘢痕成熟中起一定的作用。 Objective To investigate effects of recombinant human decorin on proliferation and biological activity of normal human skin and hypertrophic scar fibroblasts in vitro so as to explore the role of decorin in formation and mature of hypertrophic scar. Methods Fibroblasts derived from normal human skin and hypertrophic scar were harvested and cultured in vitro with recombinant human decorin of serial diluted concentration (0.01 μg/ml,0.1 μg/ml,2 μg/ml and 10 μg/ml). After 12,24 and 48 hours of culture, the cell proliferation rates were measured by MTT colorimetric determination. After 48 hours of culture,cell cycle distributions and apoptosis were analyzed with flow cytometer,followed by collection of the cell supernatants. Contents of TGF-β1 and type of Ⅰ and Ⅲ pro-collagens (PCⅠ and PC Ⅲ) in the supernatants were detected by enzyme-linked immunoabsorbent assay and radioimmunoassay,respectively. Results The proliferations of normal human skin and hypertrophic scar fibroblasts were significantly inhibited and the percent of cells at the G1 phase significantly increased by 2 μg/ml decorin ( P <0.05 or P <0.01). Contents of TGF-β1 and PCⅠand PCⅢ and the ratio of PCⅠto PCⅢ in the supernatants were significantly decreased. Cells in late apoptosis were not found in control and groups treated with decorin. Conclusions Recombinant human decorin can inhibit the proliferation and biological activity of normal human skin and hypertrophic scar fibroblasts in vitro, suggesting that decorin may be effective in preventing hypertrophic scar and scar promotion from mature.
出处 《中华创伤杂志》 CAS CSCD 北大核心 2004年第7期428-431,共4页 Chinese Journal of Trauma
基金 国家重点基础研究发展规划资助项目 (G19990 5 43 0 9)
关键词 重组核心蛋白多糖 皮肤 增生性瘢痕 成纤维细胞增殖 生物学活性 DECORIN 细胞分裂 Cicatrix,hypertrophic Fibroblasts Cell Division Decorin
  • 相关文献

参考文献9

  • 1Kresse H, Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol, 2001, 189:266-274.
  • 2Sayani K, Dodd CM, Nedelec B, et al. Delayed appearance of Decorin in healing burn scars. Histopathology, 2000, 36:262-272.
  • 3Scott PG, Ghahary A, Tredget EE. Molecular and cellular aspects of fibrosis following thermal injury. Hand Clin, 2000, 16:271-287.
  • 4Stewart JE, Wheatley DN, Holmes JD, et al. Purification and identification of a human dermal extract component inhibitory to fibroblast proliferation. Cell Biol Int, 2001, 25:607-612.
  • 5Santra M, Mann DM, Mercer EW, et al. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J Clin Invest
  • 6Stander M, Naumann U, Wick W, et al. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res, 1999, 296:221-227.
  • 7Xaus J, Comalada M, Cardo M, et al. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood, 2001, 98:2124-33.
  • 8Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature, 1990, 346:281-284.
  • 9Yeo TK, Brown L, Dvorak HF. Alterations in proteoglycan synthesis common to healing wounds and tumors. Am J Pathol, 1991, 138:1437-1450.

共引文献1

同被引文献60

  • 1张志,李孝建,梁蓉,梁达荣,李叶扬,许伟石.重组核心蛋白多糖对转化生长因子β1刺激人正常皮肤和增生性瘢痕成纤维细胞的作用[J].中国临床康复,2005,9(10):112-114. 被引量:3
  • 2熊雁,张正治.核心蛋白聚糖抑制兔屈趾肌腱术后粘连的实验研究[J].中国修复重建外科杂志,2006,20(3):251-255. 被引量:11
  • 3Mayes MD,Lacey JV Jr,Beebe-Dimmer J,et al.Prevalence,incidence,survival and disease characteristics of systemic sclerosis in a large US population.Arthritis Rheum,2003,48:2246-2255.
  • 4Sakkas LI.New developments in the pathogenesis of systemic sclerosis.Autoimmunity,2005,38:113-116.
  • 5Abdel-Wahab N,Wicks SJ,Mason RM,et al.Decorin suppresses transforming growth factor-beta-induced expression of plas-minogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+ dependent phosphorylation of Smad 2 at serine-240.Biochem J,2002,362:643-649.
  • 6Yamaguchi Y,Mann DM,Ruoslahti E.Negative regulation of transforming growth factor-beta by the proteoglycan decorin.Nature,1990,346:281-284.
  • 7Border WA,Noble NA,Yamamoto T,et al.Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease.Nature,1992,360:361-364.
  • 8Soo C,Hu FY,Zhang X,et al.Differential expression of fibro-modulin,a transforming growth factor-beta modulator,in fetal skin development and scarless repair.Am J Palhol,2000,157:423-433.
  • 9Smith EA,LeRoy EC.A possible role for transforming growth factor-α in systemic sclerosis.J Invest Dermatol,1990,95 6 Suppl:125-127.
  • 10Yamamoto T,Takagawa S,Katayama I,et al.Animal model of sclerotic skin Ⅰ:local injections of blemomycin induce sclerotic skin mimicking scleroderma.J Invest Dermatol,1999,112:456-462.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部